数百万人全球老龄化fflicted by the neurological ailment known as Alzheimer's Disease (AD). In fact, according to recent data, the number of AD patients globally is expected to quadruple by 2050. As a result, the toll that AD takes on people, families, and society at large is swiftly increasing, highlighting the increasing need for cutting-edge treatments to halt the disease's course and enhance the lives of AD patients. Lifestyle interventions may be particularly well-positioned to assist those with AD and other forms of dementia, such as Mild Cognitive Impairment (MCI), as they offer a more sustainable change through motivated behavior, while also being relatively cost-effective and feasible to implement. Pharmacological treatments, however, remain a current area of research and an important component of many individuals' care.